Novartis Investigative Site is a clinical research site located in Springfield, Missouri, United States 65802.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Novartis Investigative Site has participated in 14 clinical trials.
Therapeutic areas: Polycystic Ovary Syndrome, Atherosclerosis, Rheumatoid Arthritis.
Sponsors: Novartis Pharmaceuticals, Novartis.
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Novartis Investigative Site has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Novartis Investigative Site has 14 clinical trials on record. Their work covers Polycystic Ovary Syndrome, Atherosclerosis, Rheumatoid Arthritis.
Yes — Novartis Investigative Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.